Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

If President Donald Trump imposes drug tariffs that affect the cheap generic medicines Teva Pharmaceutical Industries makes, ...

AUSTEDO ® - shows continued strong growth, with worldwide revenues of $411 million in Q1 2025, an increase of 39% in local ...

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple ...

Teva Pharmaceutical Industries Ltd. engages ... and is involved in the distribution business of generic, biosi ...

Just a couple of basic factors—House generic ballot polling and the number of seats the presidential party is defending—do a decent job of predicting midterm congressional election results.

Along the way, though, he’s made quite a few really great records and remained absolutely, in every possible way, committed to the bit. So it is here, on his first album in 11 years, in which he doesn ...

The state began selling its own generic version of Narcan last year for $24 per twin-pack to businesses and local governments, and will now also sell to individual consumers online. A box containing ...

Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch ...

When launched, Hikma will have 180 days of U.S. generic market sales exclusivity for this product, which is the generic of Mekinist. “Hikma’s generics business is accelerating its efforts to ...

The recalled products are generic versions of Aleve (naproxen sodium), Tylenol (acetaminophen), and Advil (ibuprofen). According to an FDA report, published on April 8, the recall was initiated ...

the company said in a regulatory filing. The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of hypertension.